Please Wait.....
Report
Left Atrial Appendage (LAA) Closure Device Market By Product (Endocardial LAA Devices, Epicardial LAA Devices), By End Use (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-09-01 I 318 Pages I Allied Market Research
The globalleft atrial appendage (LAA) closure device market is envisioned to garner $8,218.10 million by 2031, growing from $1,276.90 million in 2021 at a CAGR of 20.97% from 2022 to 2031.
The globalLeft Atrial Appendage (LAA) Closuredevice is implanted in the heart and is intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The device mechanically occludes the LAA to prevent LAA thrombus from entering the circulation of the blood in the body. LAA closure reduces the stroke risk associated with atrial fibrillation. But, it doesn't treat the AFib itself. Left atrial appendage closure can benefit people who need heart surgery and also have atrial fibrillation. The procedure is also helpful for those who have atrial fibrillation.
The rising prevalence of atrial fibrillation is anticipated to augment the need for left atrial appendage closure devices. Atrial fibrillation was one the most prevalent atrial arrhythmia in patients suffering from congenital heart disease. Additionally, the aging population will increase atrial fibrillation disease incidences, as elderly adults are more susceptible to arrhythmia, ischemic stroke disease, and atrial fibrillation. Such factors are anticipated to drive theLeft Atrial Appendage (LAA) Closuredevice market value.
However, the availability of alternatives and the high cost of left atrial appendage atrial closure devices may negatively impact the market expansion. Oral anticoagulation is the conventional alternative to left atrial appendage closure devices and is extensively preferred by doctors with non-valvular atrial fibrillation. The development of non-vitamin oral anticoagulants (NOACs) such as rivaroxaban, dabigatran, apixaban, and edoxaban have facilitated the use of oral anti-coagulants among patients that are susceptible to thromboembolic events instroke management. Such factors are anticipated to restrict theLeft Atrial Appendage (LAA) Closuredevice market growth.
The COVID-19 pandemic brought several uncertainties leading to severe economic losses as various businesses across the world were at a standstill. There were import-export restrictions laid down on major Left Atrial Appendage (LAA) Closuredevice-producing countries such as theUnited Statesand China, which imposed significant challenges on the market.COVID-19 virus enhances the thrombo-inflammatory cascade, which intensifies coagulation and may increase the risk of cardiac embolism in patients with AF. The limitations regarding the ICU beds during the pandemic represent a major restriction in performing heart surgeries including left atrial appendage closure procedures, thereby reducing the usage of left atrial appendage closure devices.
The key players profiled in the Left Atrial Appendage (LAA) Closure Device market report include Boston Scientific Corporation, Abbott, Lifetech Scientific, ATRICURE, INC., SentreHEART, Inc., Medical Device Business Services, Inc., Occlutech, Cardia, Inc., Johnson & Johnson Private Limited, and Lepu Medical Technology Co., Ltd.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the left atrial appendage (LAA) closure device market analysis from 2021 to 2031 to identify the prevailing left atrial appendage (LAA) closure device market opportunities.
-Market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
-An in-depth analysis of the left atrial appendage (LAA) closure device market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global left atrial appendage (LAA) closure device market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Endocardial LAA Devices
- Epicardial LAA Devices
By End Use
- Hospitals
- Ambulatory Surgery Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA
- Key Market Players
- sentreheart, inc.
- Boston Scientific Corporation
- AtriCure, Inc.
- Abbott Laboratories
- Occlutech
- lifetech scientific corporation
- Cardia, Inc.
- Aegis Medical Group.
- Biosense Webster, Inc.
- Johnson & Johnson Services, Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Regulatory Guidelines
3.8.Value Chain Analysis
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Endocardial LAA Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Epicardial LAA Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ambulatory Surgery Centers
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product
6.2.3 North America Market size and forecast, by End Use
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Product
6.2.4.1.2 Market size and forecast, by End Use
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Product
6.2.4.2.2 Market size and forecast, by End Use
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Product
6.2.4.3.2 Market size and forecast, by End Use
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product
6.3.3 Europe Market size and forecast, by End Use
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Product
6.3.4.1.2 Market size and forecast, by End Use
6.3.4.2 United Kingdom
6.3.4.2.1 Market size and forecast, by Product
6.3.4.2.2 Market size and forecast, by End Use
6.3.4.3 France
6.3.4.3.1 Market size and forecast, by Product
6.3.4.3.2 Market size and forecast, by End Use
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Product
6.3.4.4.2 Market size and forecast, by End Use
6.3.4.5 Italy
6.3.4.5.1 Market size and forecast, by Product
6.3.4.5.2 Market size and forecast, by End Use
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Product
6.3.4.6.2 Market size and forecast, by End Use
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product
6.4.3 Asia-Pacific Market size and forecast, by End Use
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Product
6.4.4.1.2 Market size and forecast, by End Use
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Product
6.4.4.2.2 Market size and forecast, by End Use
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Product
6.4.4.3.2 Market size and forecast, by End Use
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Product
6.4.4.4.2 Market size and forecast, by End Use
6.4.4.5 Australia
6.4.4.5.1 Market size and forecast, by Product
6.4.4.5.2 Market size and forecast, by End Use
6.4.4.6 Rest Of Asia Pacific
6.4.4.6.1 Market size and forecast, by Product
6.4.4.6.2 Market size and forecast, by End Use
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product
6.5.3 LAMEA Market size and forecast, by End Use
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Product
6.5.4.1.2 Market size and forecast, by End Use
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Product
6.5.4.2.2 Market size and forecast, by End Use
6.5.4.3 UAE
6.5.4.3.1 Market size and forecast, by Product
6.5.4.3.2 Market size and forecast, by End Use
6.5.4.4 South Africa
6.5.4.4.1 Market size and forecast, by Product
6.5.4.4.2 Market size and forecast, by End Use
6.5.4.5 Rest of LAMEA
6.5.4.5.1 Market size and forecast, by Product
6.5.4.5.2 Market size and forecast, by End Use
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 sentreheart, inc.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Boston Scientific Corporation
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 AtriCure, Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Abbott Laboratories
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Occlutech
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 lifetech scientific corporation
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Cardia, Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Aegis Medical Group.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Biosense Webster, Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Johnson & Johnson Services, Inc.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, FOR ENDOCARDIAL LAA DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 3. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET FOR ENDOCARDIAL LAA DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, FOR EPICARDIAL LAA DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 5. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET FOR EPICARDIAL LAA DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 7. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 8. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. U.S. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 18. U.S. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 19. CANADA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 20. CANADA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 21. MEXICO LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 22. MEXICO LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 23. EUROPE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 24. EUROPE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 25. EUROPE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. GERMANY LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 27. GERMANY LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 28. UNITED KINGDOM LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 29. UNITED KINGDOM LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 30. FRANCE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. FRANCE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 32. SPAIN LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 33. SPAIN LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 34. ITALY LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. ITALY LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 36. REST OF EUROPE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 37. REST OF EUROPE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 38. ASIA-PACIFIC LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. ASIA-PACIFIC LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 40. ASIA-PACIFIC LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. CHINA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. CHINA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 43. JAPAN LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. JAPAN LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 45. INDIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. INDIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 47. SOUTH KOREA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. SOUTH KOREA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 49. AUSTRALIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 50. AUSTRALIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 51. REST OF ASIA PACIFIC LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. REST OF ASIA PACIFIC LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 53. LAMEA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 54. LAMEA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 55. LAMEA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 56. BRAZIL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 57. BRAZIL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 58. SAUDI ARABIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. SAUDI ARABIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 60. UAE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. UAE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 62. SOUTH AFRICA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 63. SOUTH AFRICA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 64. REST OF LAMEA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. REST OF LAMEA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 66.SENTREHEART, INC.: COMPANY SNAPSHOT
TABLE 67.SENTREHEART, INC.: OPERATING SEGMENTS
TABLE 68.SENTREHEART, INC.: PRODUCT PORTFOLIO
TABLE 69.SENTREHEART, INC.: NET SALES,
TABLE 70.SENTREHEART, INC.: KEY STRATERGIES
TABLE 71.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 72.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 73.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 74.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 75.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 76.ATRICURE, INC.: COMPANY SNAPSHOT
TABLE 77.ATRICURE, INC.: OPERATING SEGMENTS
TABLE 78.ATRICURE, INC.: PRODUCT PORTFOLIO
TABLE 79.ATRICURE, INC.: NET SALES,
TABLE 80.ATRICURE, INC.: KEY STRATERGIES
TABLE 81.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 82.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 83.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 84.ABBOTT LABORATORIES: NET SALES,
TABLE 85.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 86.OCCLUTECH: COMPANY SNAPSHOT
TABLE 87.OCCLUTECH: OPERATING SEGMENTS
TABLE 88.OCCLUTECH: PRODUCT PORTFOLIO
TABLE 89.OCCLUTECH: NET SALES,
TABLE 90.OCCLUTECH: KEY STRATERGIES
TABLE 91.LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 92.LIFETECH SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 93.LIFETECH SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 94.LIFETECH SCIENTIFIC CORPORATION: NET SALES,
TABLE 95.LIFETECH SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 96.CARDIA, INC.: COMPANY SNAPSHOT
TABLE 97.CARDIA, INC.: OPERATING SEGMENTS
TABLE 98.CARDIA, INC.: PRODUCT PORTFOLIO
TABLE 99.CARDIA, INC.: NET SALES,
TABLE 100.CARDIA, INC.: KEY STRATERGIES
TABLE 101.AEGIS MEDICAL GROUP.: COMPANY SNAPSHOT
TABLE 102.AEGIS MEDICAL GROUP.: OPERATING SEGMENTS
TABLE 103.AEGIS MEDICAL GROUP.: PRODUCT PORTFOLIO
TABLE 104.AEGIS MEDICAL GROUP.: NET SALES,
TABLE 105.AEGIS MEDICAL GROUP.: KEY STRATERGIES
TABLE 106.BIOSENSE WEBSTER, INC.: COMPANY SNAPSHOT
TABLE 107.BIOSENSE WEBSTER, INC.: OPERATING SEGMENTS
TABLE 108.BIOSENSE WEBSTER, INC.: PRODUCT PORTFOLIO
TABLE 109.BIOSENSE WEBSTER, INC.: NET SALES,
TABLE 110.BIOSENSE WEBSTER, INC.: KEY STRATERGIES
TABLE 111.JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
TABLE 112.JOHNSON & JOHNSON SERVICES, INC.: OPERATING SEGMENTS
TABLE 113.JOHNSON & JOHNSON SERVICES, INC.: PRODUCT PORTFOLIO
TABLE 114.JOHNSON & JOHNSON SERVICES, INC.: NET SALES,
TABLE 115.JOHNSON & JOHNSON SERVICES, INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET SEGMENTATION
FIGURE 2.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031
FIGURE 3.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.REGULATORY GUIDELINES
FIGURE 13.VALUE CHAIN ANALYSIS
FIGURE 14.MARKET SHARE ANALYSIS
FIGURE 15.KEY REGULATION ANALYSIS
FIGURE 16.PATENT ANALYSIS BY COMPANY
FIGURE 17.PATENT ANALYSIS BY COUNTRY
FIGURE 18.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,BY PRODUCT,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ENDOCARDIAL LAA DEVICES LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF EPICARDIAL LAA DEVICES LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031(%)
FIGURE 21.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,BY END USE,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITALS LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGERY CENTERS LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031(%)
FIGURE 25.LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET BY REGION,2021
FIGURE 26.U.S. LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 27.CANADA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 28.MEXICO LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 29.GERMANY LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 30.UNITED KINGDOM LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 31.FRANCE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 32.SPAIN LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 33.ITALY LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 34.REST OF EUROPE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 35.CHINA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 36.JAPAN LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 37.INDIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 38.SOUTH KOREA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 39.AUSTRALIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 40.REST OF ASIA PACIFIC LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 41.BRAZIL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 42.SAUDI ARABIA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 43.UAE LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 44.SOUTH AFRICA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 45.REST OF LAMEA LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICE MARKET,2021-2031($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50.COMPETITIVE DASHBOARD
FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 52.SENTREHEART, INC..: NET SALES ,($MILLION)
FIGURE 53.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 54.ATRICURE, INC..: NET SALES ,($MILLION)
FIGURE 55.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 56.OCCLUTECH.: NET SALES ,($MILLION)
FIGURE 57.LIFETECH SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 58.CARDIA, INC..: NET SALES ,($MILLION)
FIGURE 59.AEGIS MEDICAL GROUP..: NET SALES ,($MILLION)
FIGURE 60.BIOSENSE WEBSTER, INC..: NET SALES ,($MILLION)
FIGURE 61.JOHNSON & JOHNSON SERVICES, INC..: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security